Phase 1, QT/QTC Interval Study in Healthy Subjects
Clinical trial NCT01910415 · COMPLETED
Trial details
- NCT number
- NCT01910415
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-01
- Primary completion
- 2014-03-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.